Lectures

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Prof Andrew Sindone

This talk will explain how obesity drives heart failure, particularly HFpEF and will outline the recommended management of HFpEF on patients with obesity, that includes using incretin therapy.

Prof Carol Wham
0.5 EA

This talk will highlight the critical importance of early detection of age-related weakness and how timely intervention through suitable nutritional support can improve outcomes.

A/Prof Ron Dick

LDL-C drives atherosclerosis. This talk reviews the latest evidence, new LDL-C targets for at-risk groups, and current treatment options for managing this major cardiovascular risk factor.

Dr Danielle Einstein
0.5 EA

Explore what the new social media age restriction changes mean for young people, and how to provide practical tips and strategies to help support young people and their families navigate the change.

Prof Merlin Thomas
0.5 EA

Understand CKD screening priorities, risk mitigation strategies, and the role of SGLT-2 inhibitors in preventing progression and complications.

Dr Adam Nelson
0.5 EA

Explore the challenges presented by patient adherence in cardiovascular medicine, and the proven strategies effective in improving adherence rates, including the use of easily-accessible digital tools.

Expert/s: Dr Adam Nelson
A/Prof William Kemp

Learn the best practices for screening, assessing, and managing fatty liver disease to reduce liver and cardiovascular risks.

Dr Ryan De Cruz

Learn evidence-based methods for assessing and managing mild-to-moderate acne, including treatment options and patient-specific decision factors.

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
0.5 EA

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

Prof Rodney Baber AM
0.5 EA

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Dr Gabby Mahoney
0.5 EA

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

Prof Deborah Bateson AM
0.5 EA

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.

This talk will explain how obesity drives heart failure, particularly HFpEF and will outline the recommended management of HFpEF on patients with obesity, that includes using incretin therapy.

This talk will highlight the critical importance of early detection of age-related weakness and how timely intervention through suitable nutritional support can improve outcomes.

LDL-C drives atherosclerosis. This talk reviews the latest evidence, new LDL-C targets for at-risk groups, and current treatment options for managing this major cardiovascular risk factor.

Explore what the new social media age restriction changes mean for young people, and how to provide practical tips and strategies to help support young people and their families navigate the change.

Understand CKD screening priorities, risk mitigation strategies, and the role of SGLT-2 inhibitors in preventing progression and complications.

Explore the challenges presented by patient adherence in cardiovascular medicine, and the proven strategies effective in improving adherence rates, including the use of easily-accessible digital tools.

Expert/s: Dr Adam Nelson

Learn the best practices for screening, assessing, and managing fatty liver disease to reduce liver and cardiovascular risks.

Learn evidence-based methods for assessing and managing mild-to-moderate acne, including treatment options and patient-specific decision factors.

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.